Table 3. Prevalence of cancer on 31 December 2008 in the United Kingdom, by time since diagnosis.
| 0–1 years | 1–5 years | 5–10 years | 10–20 years | >20 years | Total | |
|---|---|---|---|---|---|---|
| Males | ||||||
| Colon, rectum and anus | 14 619 (49) | 38 075 (127) | 31 162 (104) | 24 534 (82) | 14 141 (47) | 122 531 (410) |
| Lung, bronchus and trachea | 8263 (28) | 7850 (26) | 3810 (13) | 4769 (16) | 14 049a (47)a | 38 741 (130) |
| Prostate | 37 967 (127) | 125 470 (419) | 61 376 (205) | 22 601 (76) | 6022 (20) | 253 436 (847) |
| All other malignant neoplasmsb | 40 891 (137) | 97 529 (326) | 87 008 (291) | 98 726 (330) | 80 326 (269) | 404 480 (1352) |
| All malignant neoplasmsb | 101 740 (340) | 268 924 (899) | 183 356 (613) | 150 630 (504) | 114 538 (383) | 819 188 (2738) |
| Females | ||||||
| Breast | 42 432 (137) | 140 111 (451) | 128 672 (414) | 145 035 (467) | 92 748 (299) | 548 998 (1,768) |
| Colon, rectum and anus | 11 309 (36) | 30 341 (98) | 27 128 (87) | 25 532 (82) | 18 975 (61) | 113 285 (365) |
| Lung, bronchus and trachea | 6905 (22) | 7255 (23) | 3671 (12) | 2682 (9) | 4268 (14) | 24 781 (80) |
| All other malignant neoplasmsb | 40 655 (131) | 109 179 (352) | 96 400 (310) | 119 366 (384) | 130 664 (421) | 496 264 (1598) |
| All malignant neoplasmsb | 101 301 (326) | 286 886 (924) | 255 871 (824) | 292 615 (942) | 246 655 (794) | 1 183 328 (3810) |
ICD=International Classification of Diseases.
The number of survivors (crude proportion per 100 000) is indicated; the sum of observed prevalence was available from cancer registry data, whereas modelled prevalence was not. Italicised numbers are those that are based on estimates of prevalence in 2004 that were at least 20% modelled.
a
The estimate of the number of long-term male lung cancer survivors (>20 years from diagnosis) is likely over-estimated; see the section ‘Discussion’ for details. A more plausible figure is 6000 (20 per 100 000).
b
Excluding non-melanoma skin cancer (ICD-10 C44).